Copyright: ©Author(s) 2026.
World J Psychiatry. Oct 19, 2026; 16(10): 122412
Published online Oct 19, 2026. doi: 10.5498/wjp.122412
Published online Oct 19, 2026. doi: 10.5498/wjp.122412
Table 1 Comparison of serum brain-derived neurotrophic factor, mature brain-derived neurotrophic factor, brain-derived neurotrophic factor precursor, aquaporin-4, and glycogen synthase kinase-3β levels between the two groups (mean ± SD)
| Characteristics | Case group (n = 31) | Control group (n = 31) | P value | t value | Effect size (Cohen′s d) |
| BDNF (ng/mL) | 13.21 ± 6.18 | 21.52 ± 6.48 | < 0.05 | -5.167 | 1.312 |
| mBDNF (pg/mL) | 537.01 ± 188.80 | 874.42 ± 463.69 | < 0.05 | -3.752 | 0.953 |
| proBDNF (pg/mL) | 1061.49 ± 451.74 | 729.10 ± 152.44 | < 0.05 | 3.882 | 0.986 |
| AQP4 (ng/mL) | 39.23 ± 19.65 | 53.45 ± 12. 99 | < 0.05 | -3.361 | 0.854 |
| GSK3β (pg/mL) | 939.69 ± 249.02 | 771.28 ± 391.72 | < 0.05 | 2.020 | 0.513 |
- Citation: Li XP, Ji HL, Luo SY, Zhu CY, Qiu YT, Zhang XL, Xu YL, Jiang L. Do serum biomarker levels correlate with anxiety disorders? World J Psychiatry 2026; 16(10): 122412
- URL: https://www.wjgnet.com/2220-3206/full/v16/i10/122412.htm
- DOI: https://dx.doi.org/10.5498/wjp.122412